Why the FDA ’s approval of revolutionary sickle cell gene therapy is a ‘big deal’

Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor…#african #fda #johnyang #yaleschoolofmedicine #cececalhoun #ginakolata
Source: Reuters: Health - Category: Consumer Health News Source Type: news